Bangladesh has launched the first-ever once-weekly oral anti-diabetic medication as a possible alternate to insulin injections for treatment of the disease.
Diabetic Association of Bangladesh President Prof AK Azad Khan was the chief guest at the clinical implication programme of the Merzev medicine at Dhaka Club in the capital on Sunday, read a press release.
BIRDEM Academy Director Prof Faruque Pathan and Bangladesh Endocrine Society President Prof SM Ashrafuzzaman were the special guests on the occasion.
At the event, Associate Prof Faria Afsana highlighted the drug's potential to significantly enhance patient adherence to diabetes treatment.
ACI Pharmaceuticals manufactured the medicine to bring a revolutionise change in diabetes management thereby elevating patients' quality of life.
